LOGO
LOGO

Economy And The Numbers

Can Komzifti's Early Adoption Support Kura Oncology's Next Phase Of Growth?

By Prabha Kurup   ✉  | Published:  | Google News Follow Us  | Join Us
komzifti 25082026 lt

FDA approval is an important milestone, but it is patient adoption that ultimately determines a therapy's commercial success.

The company we are profiling today has shown strong early market traction, securing a leading position in the menin inhibitor class within just its second full quarter after launching its acute myeloid leukemia (AML) therapy and capturing the majority of new patient starts.

Subscribe to continue reading the article.
This article is available exclusively to RTT Biotech Investor and Intelligent Investor subscribers. Subscribe with a RTTNews subscription.
Start Free Trial
FREE 7-Day Trial - No Payment Required
Already subscribed? Sign in

For comments and feedback contact: editorial@rttnews.com

Economic News

What parts of the world are seeing the best (and worst) economic performances lately? Click here to check out our Econ Scorecard and find out! See up-to-the-moment rankings for the best and worst performers in GDP, unemployment rate, inflation and much more.

Global Economics Weekly Update - Aug 31 – Sep 04, 2026

September 04, 2026 15:08 ET
The job report and foreign trade data were the main economic news from the U.S. in the first week of September. Elsewhere in North America, the Canadian central bank announced its latest policy decision. Inflation data from Eurozone was the highlight in Europe. The latest interest rate decision by the Reserve Bank of New Zealand drew attention in Asia.